CCS
SNY icon

Crosspoint Capital Strategies’s Sanofi SNY Stock Holding History

Crosspoint Capital Strategies’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,452
Closed -$203K – 707
2015
Q4 		$203K Buy
4,452
+4,149
+1,369% +$191K 0.05% 231
2015
Q3 		$14K Sell
303
-47
-13% -$2.39K 0.02% 378
2015
Q2 		$17K Hold
350
– – ﹤0.01% 442
2015
Q1 		$17K Sell
350
-132
-27% -$6.31K 0.01% 354
2014
Q4 		$22K Sell
482
-3,336
-87% -$162K 0.01% 429
2014
Q3 		$215K Buy
3,818
+64
+2% +$3.44K 0.16% 101
2014
Q2 		$192K Buy
3,754
+626
+20% +$33.2K 0.07% 133
2014
Q1 		$164K Hold
3,128
– – 0.07% 139
2013
Q4 		$163K Buy
+3,128
New +$161K 0.05% 145

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Crosspoint Capital Strategies's SNY Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Sanofi (SNY) in Q1 2016, closing a stake of 4,452 shares — an estimated $203K sold.

Crosspoint Capital Strategies first reported a position in SNY in Q4 2013 and held it in 9 quarters. The position peaked at $215K in Q3 2014. 449 funds tracked by Wall St. Rank hold SNY as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Sanofi position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 4,452 Sanofi shares in Q1 2016, an estimated $203K.
  • Crosspoint Capital Strategies first reported a position in Sanofi in Q4 2013 and held it in 9 quarters.
  • Crosspoint Capital Strategies's Sanofi position peaked at $215K in Q3 2014.
  • 449 funds tracked by Wall St. Rank held Sanofi as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.